§ 13F · FUND PROFILE
SILVERARC CAPITAL MANAGEMENT, LLC.
Institutional filer · behavioral pattern: Other. Summary pending.
AUM · $741.6T (13F)Positions · 82Turnover · — · Q4Filed · Feb 12, 2026
CONCENTRATION
—
Top 10 holdings
NEW BUYS
0
+$107.4T deployed
EXITS
0
No exits
SECTOR SHIFT
—
No prior quarter data
3YR HIT RATE
—
Top-5 overlap
§ 01 · TOP HOLDINGS
The book · Q4 2025
FILED FEB 12, 2026
| # | Ticker | Name | Shares | $ value | % port | Δ Q4 |
|---|---|---|---|---|---|---|
| 1 | ABVX | ABIVAX SA | 422K | $56.9T | 7.9% | −22% |
| 2 | COGT | COGENT BIOSCIENCES INC | 1.25M | $44.2T | 6.1% | +53% |
| 3 | URGN | UROGEN PHARMA LTD | 1.74M | $40.7T | 5.7% | +10% |
| 4 | KALV | KALVISTA PHARMACEUTICALS INC | 2.43M | $39.2T | 5.4% | +78% |
| 5 | CELC | CELCUITY INC | 375K | $37.4T | 5.2% | +323% |
| 6 | NUVL | NUVALENT INC | 311K | $31.3T | 4.4% | −16% |
| 7 | DNTH | DIANTHUS THERAPEUTICS INC | 750K | $30.9T | 4.3% | +11% |
| 8 | KOD | KODIAK SCIENCES INC | 1.02M | $28.6T | 4.0% | +2% |
| 9 | PRAX | PRAXIS PRECISION MEDICINES I | 82K | $24.3T | 3.4% | +61% |
| 10 | IMNM | IMMUNOME INC | 1.13M | $24.2T | 3.4% | NEW |
§ 02 · SECTOR ALLOCATION
Where the money is
Sector data pending
§ 03 · THE SILVERARC SIGNAL
AC read
SILVERARC CAPITAL MANAGEMENT, LLC is a Other fund managing $741600.8 trillion in assets. The fund runs a portfolio of 82 positions.
Read the full dossier →§ 04 · FILING HISTORY
Q-by-Q deltas
1 FILINGS
Q4 2025
Steady book
+0 buys · −0 exits · 0 changed
Q3 2025
Steady book
+0 buys · −0 exits · 0 changed
Q1 2025
Steady book
+0 buys · −0 exits · 0 changed